NEW YORK, Oct. 10, 2024 /PRNewswire/ — Ulike, the global leader of at-home IPL (Intense Pulsed Light) laser hair removal, is thrilled to announce the launch of Ulike X, the first professional IPL hair… Read More »Ulike Unveils Ulike X, Its First Men’s Hair Removal Device in North America
Impact Analytics Study Reveals Surge in Healthy Food Sales, with Midwest States Seeing the Most Significant Impact NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — Calorie consumption is expected to decline by approximately 10 trillion… Read More »Americans Expected to Reduce Calorie Intake by Trillions as GLP-1 Usage Rises, According to New Study
66% of Respondents Claim Only Nominal Effectiveness with Current Threat Intelligence Tools IRVINE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) — In a release issued earlier, the link to the webinar should have been http://www.tacitred.com/asm24webinar/. The corrected… Read More »CORRECTION — Survey Reveals that Half of U.S. Enterprises Have Immature External Attack Surface Management Programs Despite 90% Indicating Increases in Impactful Incidents
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — The Rare Utility Memecoin Takes a Major Step Toward Increased Scarcity and New Utility PepeCoin, the OG 2016 memecoin known for its rarity and utility, is about… Read More »PepeCoin Announces Exclusive Burn Event for BasedAI Network Integration
AI-Powered Threat Intelligence Delivers Enhanced Visibility, Faster Detection, and Proactive Response Across the Entire Ransomware Lifecycle BOSTON, Oct. 9, 2024 /PRNewswire/ — Recorded Future, the world’s largest threat intelligence company, today announced new industry-first… Read More »Recorded Future Unveils AI-Driven Enhancements to Combat Ransomware Threats with Real-Time Intelligence
ADELAIDE, South Australia, Oct. 9, 2024 /PRNewswire/ — BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Centivax, Inc., for a project involving cell line… Read More »Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine